Insider Transactions in Q2 2024 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2024
|
Jeffrey L. Ives |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+43.15%
|
-
|
|
Jun 04
2024
|
Lisa Von Moltke |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+45.15%
|
-
|
|
Jun 04
2024
|
Helen M Boudreau |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+50.0%
|
-
|
|
Jun 04
2024
|
Martin Vogelbaum |
BUY
Grant, award, or other acquisition
|
Direct |
301,295
+42.3%
|
-
|
|
Jun 04
2024
|
Susan Ph.D. Shiff |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+42.71%
|
-
|
|
May 02
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,936
-2.18%
|
$0
$0.75 P/Share
|
|
Apr 05
2024
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,753
-3.03%
|
$0
$0.83 P/Share
|
|
Apr 05
2024
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,753
-4.91%
|
$0
$0.83 P/Share
|